| |
 |
Editorial [ Drug Discovery for Alzheimer's Disease: Filling the Pipeline Guest Editors: Antony R. Horton and Howard M. Fillit ]
|
| |
|
pp.501-502 (2) Authors: Antony R. Horton, Howard M. Fillit
|
| |
|
|
| |
|
Small Molecule Neurotrophin Receptor Ligands: Novel Strategies for Targeting Alzheimer's Disease Mechanisms
|
| |
|
pp.503-506 (4) Authors: Frank M. Longo, Tao Yang, Juliet K. Knowles, Youmei Xie, Laura A. Moore, Stephen M. Massa
|
| |
|
|
| |
|
NAP, A Neuroprotective Drug Candidate in Clinical Trials, Stimulates Microtubule Assembly in the Living Cell
|
| |
|
pp.507-509 (3) Authors: Illana Gozes, Inna Divinski
|
| |
|
|
| |
|
Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
|
| |
|
pp.510-517 (8) Authors: Jun Ming Wang, Ronald W. Irwin, Lifei Liu, Shuhua Chen, Roberta Diaz Brinton
|
| |
|
|
| |
|
Oligomers of β-Amyloid Peptide Inhibit BDNF-Induced Arc Expression in Cultured Cortical Neurons
|
| |
|
pp.518-521 (4) Authors: Valentine Echeverria, Diego E. Berman, Ottavio Arancio
|
| |
|
|
| |
|
Novel Multifunctional Anti-Alzheimer Drugs with Various CNS Neurotransmitter Targets and Neuroprotective Moieties
|
| |
|
pp.522-536 (15) Authors: Cornelis J. Van der Schyf, Silvia Mandel, Werner J. Geldenhuys, Tamar Amit, Yael Avramovich, Hailin Zheng, Mati Fridkin, Shunit Gal, Orly Weinreb, Orit Bar Am, Yotam Sagi, Moussa B.H. Youdim
|
| |
|
|
| |
|
Detrimental Effects of Apolipoprotein E4: Potential Therapeutic Targets in Alzheimer's Disease
|
| |
|
pp.537-540 (4) Authors: Robert W. Mahley, Yadong Huang, Karl H. Weisgraber
|
| |
|
|
| |
|
APP-Based Neuroprotective Strategies
|
| |
|
pp.541-543 (3) Authors: Dale E. Bredesen, Shahrooz Rabizadeh
|
| |
|
|
| |
|
Inhibition of Tau Aggregation in Cell Models of Tauopathy
|
| |
|
pp.544-546 (3) Authors: Inna Khlistunova, Marcus Pickhardt, Jacek Biernat, Yipeng Wang, Eva-Maria Mandelkow, Eckhard Mandelkow
|
| |
|
|
| |
|
New Approaches to the Discovery of cdk5 Inhibitors
|
| |
|
pp.547-549 (3) Authors: Marcie A. Glicksman, Gregory D. Cuny, Min Liu, Brittany Dobson, Kenneth Auerbach, Ross L. Stein, Kenneth S. Kosik
|
| |
|
|
| |
|
Perispinal Etanercept for Treatment of Alzheimer's Disease
|
| |
|
pp.550-552 (3) Author: Edward Tobinick
|
| |
|
|
| |
|
Memory Improvement with Docosahexaenoic Acid Study (MIDAS)-Brief Review
|
| |
|
pp.553-555 (3) Author: Karin Yurko-Mauro
|
| |
|
|
| |
|
Is Alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
|
| |
|
pp.556-561 (6) Authors: Manfred Windisch, Hans-Jorg Wolf, Birgit Hutter-Paier, Robert Wronski
|
| |
|
|
| |
|
Discovery of ADDL-Targeting Small Molecule Drugs for Alzheimer's Disease
|
| |
|
pp.562-567 (6) Authors: Gary C. Look, Jasna Jerecic, Diana B. Cherbavaz, Todd R. Pray, Jean-Claude R. Breach, Walter J. Crosier, Lev Igoudin, Catherine M. Hironaka, Raymond M. Lowe, Michele McEntee, Lily Ruslim-Litrus, Hsiu-Mei Wu, Sue Zhang, Susan M. Catalano, William F. Goure, David Summa, Grant A. Krafft
|
| |
|
|
| |
|
Nogo Receptor Interacts with Brain APP and Aβ to Reduce Pathologic Changes in Alzheimer's Transgenic Mice
|
| |
|
pp.568-570 (3) Authors: James H. Park, Stephen M. Strittmatter
|
| |
|
|
